Combination of Nigella sativa and Honey in Eradication of Gastric Helicobacter pylori Infection

Fataneh Hashem-Dabaghian, Shahram Agah, Maryam Taghavi-Shirazi, Ali Ghobadi, Fataneh Hashem-Dabaghian, Shahram Agah, Maryam Taghavi-Shirazi, Ali Ghobadi

Abstract

Background: Gastric Helicobacter pylori is extremely common worldwide.

Objectives: The aim of this study was to assess the effectiveness of combination of Nigella sativa and honey (Dosin) in eradication of gastric H. pylori infection.

Patients and methods: Nineteen patients who had positive result for H. pylori infection by urea breath test (UBT) without a past history of peptic ulcer, gastric cancer or gastrointestinal bleeding, were suggested to receive one teaspoon of the mixture of Dosin (6 g/day of N. sativa as ground seeds and 12 g/day of honey) three times a day after meals for two weeks. The second UBT was used to detect the presence of H. pylori four weeks after completion of the test. In addition, symptoms of dyspepsia were scored before and after the study and analyzed with Wilcoxon signed-rank test.

Results: Fourteen patients completed the study. Negative UBT was observed in 57.1% (8/14) of participants after intervention. The median and interquartile range (IQR) of total dyspepsia symptoms was significantly reduced from 5.5 (5 - 12) to 1 (0 - 4) (P = 0.005). All the patients tolerated Dosin except for one who was excluded due to mild diarrhea. No serious adverse events were reported.

Conclusions: Dosin was concluded to be an anti H. pylori and an anti-dyspeptic agent. Further studies are recommended to investigate the effect of Dosin plus antibiotics (concurrently or following another) on gastric H. pylori infection.

Keywords: Helicobacter pylori; Honey; Medicine; Nigella sativa; Phytotherapy; Traditional.

Figures

Figure 1.. Flow Diagram of the Study
Figure 1.. Flow Diagram of the Study
W, weeks; if, loss to follow up.

References

    1. Sayehmiri F, Darvishi Z, Sayehmiri K, Soroush S, Emaneini M, Zarrilli R, et al. A Systematic Review and Meta-Analysis Study to Investigate the Prevalence of Helicobacter pylori and the Sensitivity of its Diagnostic Methods in Iran. Iran Red Crescent Med J. 2014;16(6):ee12581. doi: 10.5812/ircmj.12581.
    1. Longo D, Fauc A, Kasper D, Hauser S, Jameson J, Loscalzo J. Harrison's Principles of Internal Medicine . 18 ed. USA: Mc GrawHill; 2012. pp. 1261–5.
    1. Chey WD, Wong BC, Practice Parameters Committee of the American College of G. American College of Gastroenterology guideline on the management of Helicobacter pylori infection. Am J Gastroenterol. 2007;102(8):1808–25. doi: 10.1111/j.1572-0241.2007.01393.x.
    1. Khan MQ. Helicobacter pylori Eradication Therapy in Nonulcer Dyspepsia is Beneficial. Saudi J Gastroenterol. 2008;14(2):96–100. doi: 10.4103/1319-3767.39629.
    1. Tepes B, O'Connor A, Gisbert JP, O'Morain C. Treatment of Helicobacter pylori infection 2012. Helicobacter. 2012;17 Suppl 1:36–42. doi: 10.1111/j.1523-5378.2012.00981.x.
    1. Khaleghi S, Taher MT, Naghibi SS, Naghibi SM. Comparison of sequential and routine four drugs therapeutic regiments in Helicobacter pylori eradication. J Gorgan Uni Med Sci. 2013;15(3)
    1. Duck WM, Sobel J, Pruckler JM, Song Q, Swerdlow D, Friedman C, et al. Antimicrobial resistance incidence and risk factors among Helicobacter pylori-infected persons, United States. Emerg Infect Dis. 2004;10(6):1088–94. doi: 10.3201/eid1006.030744.
    1. Aghili Khorasani M. Makhzan-al-Adviah. Tehran: Sabzara publications; 2011. pp. 545–63.
    1. Ali BH, Blunden G. Pharmacological and toxicological properties of Nigella sativa. Phytother Res. 2003;17(4):299–305. doi: 10.1002/ptr.1309.
    1. Salehi Surmaghi M. Medicinal Plants and Phytotherapy. Tehran: World of Nutrition publications; 2007. p. 216.
    1. Soltani A. Encyclopedia of Traditional Medicine (medicinal plants). Tehran: Arjomand publications; 2004. p. 397.
    1. Ahmad A, Husain A, Mujeeb M, Khan SA, Najmi AK, Siddique NA. A review on therapeutic potential of Nigella sativa: A miracle herb. Asian Pacific J Tropical Biomedicine. 2013;3(5):337–52.
    1. Khan SA, Khan AM, Karim S, Kamal MA, Damanhouri GA, Mirza Z. Panacea seed "Nigella": A review focusing on regenerative effects for gastric ailments. Saudi J Biologic Sci. 2014
    1. Toppozada HH, Mazloum HA, el-Dakhakhny M. The antibacterial properties of the Nigella sativa l. seeds. Active principle with some clinical applications. J Egypt Med Assoc. 1965;48:Suppl:187–202.
    1. O'Mahony R, Al-Khtheeri H, Weerasekera D, Fernando N, Vaira D, Holton J, et al. Bactericidal and anti-adhesive properties of culinary and medicinal plants against Helicobacter pylori. World J Gastroenterol. 2005;11(47):7499–507.
    1. Atapour M, Zahedi MJ, Mehrabani M, Safavi M, Keyvanfard V, Foroughi A. In vitro susceptibility of the Gram-negative bacterium Helicobacter pylori to extracts of Iranian medicinal plants. Pharmaceut Biol. 2009;49(1):77–80.
    1. Hajimahmoodi M, Shams-Ardakani M, Saniee P, Siavoshi F, Mehrabani M, Hosseinzadeh H, et al. In vitro antibacterial activity of some Iranian medicinal plant extracts against Helicobacter pylori. Nat Prod Res. 2011;25(11):1059–66. doi: 10.1080/14786419.2010.501763.
    1. Biglar M, Sufi H, Bagherzadeh K, Amanlou M, Mojab F. Screening of 20 commonly used Iranian traditional medicinal plants against urease. Iran J Pharm Res. 2014;13(Suppl):195–8.
    1. Salem EM, Yar T, Bamosa AO, Al-Quorain A, Yasawy MI, Alsulaiman RM, et al. Comparative study of Nigella Sativa and triple therapy in eradication of Helicobacter Pylori in patients with non-ulcer dyspepsia. Saudi J Gastroenterol. 2010;16(3):207–14. doi: 10.4103/1319-3767.65201.
    1. Nzeako BC, Al-Namaani F. The antibacterial activity of honey on helicobacter pylori. Sultan Qaboos Univ Med J. 2006;6(2):71–6.
    1. Manyi-Loh CE, Clarke AM, Green E, Ndip RN. Inhibitory and bactericidal activity of selected South African honeys and their solvent extracts against clinical isolates of Helicobacter pylori. Pak J Pharm Sci. 2013;26(5):897–906.
    1. Matongo F, Nwodo UU. In vitro assessment of Helicobacter pylori ureases inhibition by honey fractions. Arch Med Res. 2014;45(7):540–6. doi: 10.1016/j.arcmed.2014.09.001.
    1. Manyi-Loh CE, Clarke AM, Munzhelele T, Green E, Mkwetshana NF, Ndip RN. Selected South African honeys and their extracts possess in vitro anti-Helicobacter pylori activity. Arch Med Res. 2010;41(5):324–31. doi: 10.1016/j.arcmed.2010.08.002.
    1. Reyshahry M. Hadith Encyclopedia of Medicine. Qom,Iran: Darolhadith publications; 2010. pp. 431–3.
    1. Tack J, Talley NJ, Camilleri M, Holtmann G, Hu P, Malagelada JR, et al. Functional gastroduodenal disorders. Gastroenterology. 2006;130(5):1466–79. doi: 10.1053/j.gastro.2005.11.059.
    1. Loh KY, Siang TK. Understanding non ulcer dyspepsia. Med J Malaysia. 2008;63(2):174–6. quiz 177.
    1. Fujiwara Y, Arakawa T. Overlap in patients with dyspepsia/functional dyspepsia. J Neurogastroenterol Motil. 2014;20(4):447–57. doi: 10.5056/jnm14080.
    1. Bukhari MH, Khalil J, Qamar S, Qamar Z, Zahid M, Ansari N, et al. Comparative gastroprotective effects of natural honey, Nigella sativa and cimetidine against acetylsalicylic acid induced gastric ulcer in albino rats. J Coll Physicians Surg Pak. 2011;21(3):151–6.
    1. Fischbach LA, Goodman KJ, Feldman M, Aragaki C. Sources of variation of Helicobacter pylori treatment success in adults worldwide: a meta-analysis. Int J Epidemiol. 2002;31(1):128–39.
    1. Magdy MA, Hanan el A, Nabila el M. Thymoquinone: Novel gastroprotective mechanisms. Eur J Pharmacol. 2012;697(1-3):126–31. doi: 10.1016/j.ejphar.2012.09.042.
    1. Molan P. The antibacterial activity of honey: The nature of the antibacterial activity. Bee World. 1992;73(1):5–28.
    1. Somerfield SD. Honey and healing. J R Soc Med. 1991;84(3):179.

Source: PubMed

Sponsors and Collaborators

Medical Conditions

Drug Interventions

3
Subscribe